Single-inhaler triple therapy utilizing the once-daily combination of fluticasone furoate, umeclidinium and vilanterol in the management of COPD: the current evidence base and future prospects

Maintenance pharmacological treatment for stable chronic obstructive pulmonary disease (COPD) is based on inhaled drugs, including long-acting muscarinic receptor antagonists (LAMA), long-acting β(2)-adrenoceptor agonists (LABA) and inhaled corticosteroids (ICS). Inhaled pharmacological treatment ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Malerba, Mario, Nardin, Matteo, Santini, Giuseppe, Mores, Nadia, Radaeli, Alessandro, Montuschi, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941662/
https://www.ncbi.nlm.nih.gov/pubmed/29537340
http://dx.doi.org/10.1177/1753466618760779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941662/
https://www.ncbi.nlm.nih.gov/pubmed/29537340
http://dx.doi.org/10.1177/1753466618760779

Ejemplares similares